The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“acetate and propionate, but not butyrate, stimulate the expansion of pre-existing colonic Tregs (cTregs)”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Smith et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“and on DCs, conferring a higher capacity to drive naïve T cell differentiation into Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [40]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [31]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs serve as ligands for GPR41 and GPR43 on intestinal Tregs and epithelial cells, leading to activation mitogen-activated protein kinase signaling and secretion of chemokines and cytokines11,40.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs have context-dependent functions: they can promote the expansion of Treg cells and also improve effector T cell functions133–136.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [134]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“While the gut microbiota composition is divergent across individuals, functional gene profiles are quite similar (24, 25), and alterations to common gut microbial metabolic pathways may affect production of symbiotic factors, such as SCFA, which regulate intestinal adaptive immune responses and promote health.”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“The western dietary pattern, specifically reduced ingestion of plant-based fibers, may be a critical factor that links the gut microbiome to disease (23).”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“Gut microbiota-host immune misadaptation has been implicated in the rising incidence of IBD, other inflammatory diseases, and obesity (22).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Disruption of this homeostasis leads to intestinal inflammation and disease (2, 3).”
BackgroundInduction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · cited 4×
“The antibiotic vancomycin, which targets Gram-positive bacteria and disrupts the gut microbiota (12), reduces cTregs to similar levels as observed in GF mice (7) (fig.”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“Humans and mice rely on bacteria to breakdown undigestible dietary components, such as fibers (8).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119 · cited 2×
“In SPF mice, SCFA are taken up by colonic epithelial cells but also diffuse through the epithelium into the lamina propria where they can mediate their effects directly (9, 14).”
BackgroundBifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387 · cited 1×
“These results may explain the benefits of dietary fibers and bacteria, such as clostridia and bifidobacteria (13) that can increase colonic luminal SCFA production and modulate inflammation in mice and humans.”
Background
Cited by
Items 1,001–1,070 of 1,070
Mohebali, N., Weigel, M., Hain, T., Sütel, M., Bull, J., Kreikemeyer, B., & Breitrück, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115568 · Cited by 138
Verma, A., Bhagchandani, T., Rai, A., Nikita, N., Sardarni, U. K., Bhavesh, N. S., Gulati, S., Malik, R., & Tandon, R. (2024) · ACS Omega · doi:10.1021/acsomega.3c05846 · Cited by 136
Gut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Li, L., Rao, S., Cheng, Y., Zhuo, X., Deng, C., Xu, N., Zhang, H., & Yang, L. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.810 · Cited by 109
“Specific strains had effects on specific immune cells, (Goto et al., F I G U R E 3 (a) SCFAs owns the ability to influence Tregs development through membrane protein (SLC5A8, GPR41, GPR43, GPR109A), which can promote an anti‐inflammatory environment.”
BackgroundHealthy hosts rule within: ecological forces shaping the gut microbiota
Byndloss, M. X., Pernitzsch, S. R., & Bäumler, A. J. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0010-y · Cited by 109
Can we ‘seize’ the gut microbiota to treat epilepsy?
De Caro, C., Iannone, L. F., Citraro, R., Striano, P., De Sarro, G., Constanti, A., Cryan, J. F., & Russo, E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.002 · Cited by 110
Bacterial Lipodipeptide, Lipid 654, Is a Microbiome-Associated Biomarker for Multiple Sclerosis
Farrokhi, V., Nemati, R., Nichols, F. C., Yao, X., Anstadt, E., Fujiwara, M., Grady, J., Wakefield, D., Castro, W., Donaldson, J., et al. (2013) · Clinical & Translational Immunology · doi:10.1038/cti.2013.11 · Cited by 109
Gut microbiome and bone: To build, destroy, or both?
Yan, J., & Charles, J. F. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0382-z · Cited by 108
Aleti, G., Baker, J. L., Tang, X., Alvarez, R., Dinis, M., Tran, N. C., Melnik, A. V., Zhong, C., Ernst, M., Dorrestein, P. C., et al. (2019) · mBio · doi:10.1128/mbio.00321-19 · Cited by 107
Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice
Zhai, S., Qin, S., Li, L., Zhu, L., Zou, Z., & Wang, L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz153 · Cited by 101
Regulation of humoral immunity by gut microbial products
Kim, M., & Kim, C. H. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1299311 · Cited by 104
“HDAC inhibition-mediated FoxP3 expression.(34) In line with this, SCFAs increase Tfh cell differentiation in vitro via metabolic regulation.”
BackgroundBone Remodeling and the Microbiome
Pacifici, R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031203 · Cited by 101
“Importantly, SCFAs modulate cytokine production and induce expansion of Treg cells (Arpaia et al. 2013; Furusawa et al. 2013; Smith et al. 2013) through multiple mechanisms (Zeng and Chi 2015).”
BackgroundWood, L. G. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-124aw · Cited by 99
Cheng, L., Jin, H., Qiang, Y., Wu, S., Yan, C., Han, M., Xiao, T., Yan, N., An, H., Zhou, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.018 · Cited by 98
Chen, H., Ma, X., Liu, Y., Ma, L., Chen, Z., Lin, X., Si, L., Ma, X., & Chen, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01662 · Cited by 96
“SCFAs were reported to promote production of anti-inflammatory cytokines transforming growth factor-β (TGFβ) and IL-10, then activate Treg cells and modulate inflammatory and immune responses in host (36).”
BackgroundGut–kidney crosstalk in septic acute kidney injury
Zhang, J., Ankawi, G., Sun, J., Digvijay, K., Yin, Y., Rosner, M. H., & Ronco, C. (2018) · Critical Care · doi:10.1186/s13054-018-2040-y · Cited by 95
“SCFAs can directly affect Treg cells [52, 53], neutrophils [54], monocytes [55], and mast cell [56] through the GPRs expressed on them, which will modulate the immune homeostasis of the body.”
BackgroundAging and the mucosal immune system in the intestine
Mabbott, N. A., Kobayashi, A., Sehgal, A., Bradford, B. M., Pattison, M., & Donaldson, D. S. (2015) · Biogerontology · doi:10.1007/s10522-014-9498-z · Cited by 95
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets
Gong, X., Cai, Q., Liu, X., An, D., Zhou, D., Luo, R., Peng, R., & Hong, Z. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104899 · Cited by 91
Fajstova, A., Galanova, N., Coufal, S., Malkova, J., Kostovcik, M., Cermakova, M., Pelantova, H., Kuzma, M., Sediva, B., Hudcovic, T., et al. (2020) · Cells · doi:10.3390/cells9122701 · Cited by 90
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Alteration of the Gut Microbiome in Inflammatory Bowel Disease
Andoh, A., & Nishida, A. (2023) · Digestion · doi:10.1159/000525925 · Cited by 88
Lou, X., Xue, J., Shao, R., Yang, Y., Ning, D., Mo, C., Wang, F., & Chen, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063543 · Cited by 87
(2015) · PubMed · Cited by 86
The microbiota and chronic kidney diseases: a double‐edged sword
Felizardo, R. J. F., Castoldi, A., Andrade‐Oliveira, V., & Câmara, N. O. S. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.36 · Cited by 85
Jang, D., Shin, J., Shim, E., Ohtani, N., & Jeon, O. H. (2024) · Aging Cell · doi:10.1111/acel.14315 · Cited by 84
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?
Finlay, B. B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., & Zitvogel, L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0374-6 · Cited by 81
Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages
Wu, T., Li, H., Su, C., Xu, F., Yang, G., Sun, K., Xu, M., Lv, N., Meng, B., Liu, Y., et al. (2020) · mSystems · doi:10.1128/msystems.00587-20 · Cited by 78
Engineering microphysiological immune system responses on chips
Miller, C. P., Shin, W., Ahn, E. H., Kim, H. J., & Kim, D.-H. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.01.003 · Cited by 74
Intestinal immune responses to commensal and pathogenic protozoa
Sardinha-Silva, A., Alves-Ferreira, E. V. C., & Grigg, M. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963723 · Cited by 72
Roles of the intestinal microbiota and microbial metabolites in acute GVHD
Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71
Temporal microbiota changes of high-protein diet intake in a rat model
Mu, C., Yang, Y., Luo, Z., & Zhu, W. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.06.003 · Cited by 67
Paun, A., & Danska, J. S. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12424 · Cited by 67
“role in suppressing an excessive immune reaction following pathogen clearance by effector T cells and protection against autoimmunity.(52)”
BackgroundGrey, M. J., De Luca, H., Ward, D. V., Kreulen, I. A. M., Bugda Gwilt, K., Foley, S. E., Thiagarajah, J. R., McCormick, B. A., Turner, J. R., & Lencer, W. I. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153519 · Cited by 65
“WT and Ern2–/– GF mice received either regular drinking water or drinking water supplemented with 100 mM sodium butyrate (A11079 Alfa Aesar) (33) for into recipient mice.”
BackgroundMethodInfluentialAlterations of the murine gut microbiome with age and allergic airway disease
Vital, M., Harkema, J. R., Rizzo, M., Tiedje, J., & Brandenberger, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/892568 · Cited by 65
Fecal microbiota signatures of adult patients with different types of short bowel syndrome
Huang, Y., Guo, F., Li, Y., Wang, J., & Li, J. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13806 · Cited by 64
Byrd, A. L., Liu, M., Fujimura, K. E., Lyalina, S., Nagarkar, D. R., Charbit, B., Bergstedt, J., Patin, E., Harrison, O. J., Quintana-Murci, L., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200606 · Cited by 63
Feng, P., Zhao, S., Zhang, Y., & Li, E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1123462 · Cited by 62
Asthma in the Precision Medicine Era: Biologics and Probiotics
Chiu, C.-J., & Huang, M.-T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094528 · Cited by 60
Kearney, S. M., Gibbons, S. M., Poyet, M., Gurry, T., Bullock, K., Allegretti, J. R., Clish, C. B., & Alm, E. J. (2018) · The ISME Journal · doi:10.1038/s41396-018-0192-z · Cited by 59
The dark side of Tregs during aging
Palatella, M., Guillaume, S. M., Linterman, M. A., & Huehn, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940705 · Cited by 58
Høgh, R. I., Møller, S. H., Jepsen, S. D., Mellergaard, M., Lund, A., Pejtersen, M., Fitzner, E., Andresen, L., & Skov, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000162r · Cited by 56
Carafa, I., Stocco, G., Franceschi, P., Summer, A., Tuohy, K. M., Bittante, G., & Franciosi, E. (2019) · Food Research International · doi:10.1016/j.foodres.2018.08.069 · Cited by 52
How diet can impact gut microbiota to promote or endanger health
Chassaing, B., Vijay-Kumar, M., & Gewirtz, A. T. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000401 · Cited by 52
Jiang, J., Chu, C., Wu, C., Wang, C., Zhang, C., Li, T., Zhai, Q., Yu, L., Tian, F., & Chen, W. (2021) · Food & Function · doi:10.1039/d0fo03203d · Cited by 52
Maltz, R. M., Keirsey, J., Kim, S. C., Mackos, A. R., Gharaibeh, R. Z., Moore, C. C., Xu, J., Bakthavatchalu, V., Somogyi, A., & Bailey, M. T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196961 · Cited by 51
Earl, D. C., Ferrell, P. B., Leelatian, N., Froese, J. T., Reisman, B. J., Irish, J. M., & Bachmann, B. O. (2018) · Nature Communications · doi:10.1038/s41467-017-02470-8 · Cited by 48
The environmental microbiome, allergic disease, and asthma
Kelly, M. S., Bunyavanich, S., Phipatanakul, W., & Lai, P. S. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.06.006 · Cited by 47
Microbiota Modulation of Myeloid Cells in Cancer Therapy
Goldszmid, R. S., Dzutsev, A., Viaud, S., Zitvogel, L., Restifo, N. P., & Trinchieri, G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0225 · Cited by 46
Li, Y., Ye, Z., Zhu, J., Fang, S., Meng, L., & Zhou, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844335 · Cited by 45
Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes
Semenkovich, N. P., Planer, J. D., Ahern, P. P., Griffin, N. W., Lin, C. Y., & Gordon, J. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617793113 · Cited by 45
Huang, M.-T., Chiu, C.-J., Tsai, C.-Y., Lee, Y.-R., Liu, W.-L., Chuang, H.-L., & Huang, M.-T. (2023) · Journal of Allergy and Clinical Immunology: Global · doi:10.1016/j.jacig.2023.100163 · Cited by 45
The intersect of genetics, environment, and microbiota in asthma-perspectives and challenges
Tang, H. H. F., Teo, S. M., Sly, P. D., Holt, P. G., & Inouye, M. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.026 · Cited by 43
Wangchuk, P., Shepherd, C., Constantinoiu, C., Ryan, R. Y. M., Kouremenos, K. A., Becker, L., Jones, L., Buitrago, G., Giacomin, P., Wilson, D., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00851-18 · Cited by 42
“Butyrate and propionate 357 have also been implicated in the maintenance of host immune function by signaling to epithelial 358 cells, maintaining regulatory T cell populations and inhibiting macrophage activation (67, 68).”
BackgroundFacts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Davar, D., & Zarour, H. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1129 · Cited by 40
Yamamoto, Y., Nakanishi, Y., Murakami, S., Aw, W., Tsukimi, T., Nozu, R., Ueno, M., Hioki, K., Nakahigashi, K., Hirayama, A., et al. (2018) · Microorganisms · doi:10.3390/microorganisms6040101 · Cited by 30
Qiao, S., Lian, X., Yue, M., Zhang, Q., Wei, Z., Chen, L., Xia, Y., & Dai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107047 · Cited by 30
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
A review of mathematical modeling of bone remodeling from a systems biology perspective
Cook, C. V., Lighty, A. M., Smith, B. J., & Ford Versypt, A. N. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1368555 · Cited by 25
Applications of gut microbiota in patients with hematopoietic stem-cell transplantation
Yu, J., Sun, H., Cao, W., Han, L., Song, Y., Wan, D., & Jiang, Z. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00194-y · Cited by 25
Zhang, S., Zhao, T., Wang, Y., Mi, J., Liu, J., Fan, X., Niu, R., & Sun, Z. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113866 · Cited by 25
Jia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22
Malczewski, A. B., Ketheesan, N., Coward, J. I. G., & Navarro, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624434 · Cited by 22
Slattery, J., MacFabe, D., Kahler, S., & Frye, R. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160905123953 · Cited by 20
Martens, E. C. (2016) · Nature · doi:10.1038/529158a · Cited by 20
The role of microbiota in allogeneic hematopoietic stem cell transplantation
Chang, C.-C., Hayase, E., & Jenq, R. R. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1872541 · Cited by 20
“the cytokine profiles and drive colonic regulatory T cells (Tregs) differentiation [60,99].”
BackgroundPrebiotics in atopic dermatitis prevention and management
Lee, Y. H., Verma, N. K., & Thanabalu, T. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104352 · Cited by 19
Zhu, S.-Q., Liu, J., Han, B., Zhao, W.-P., Zhou, B.-H., Zhao, J., & Wang, H.-W. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2021.118381 · Cited by 17
Regulatory T Cells: Central Concepts from Ontogeny to Therapy
Khor, B. (2017) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2016.07.003 · Cited by 15
“microbial products as therapeutic agents [97-100].”
Funayama, E., Hosonuma, M., Tajima, K., Isobe, J., Baba, Y., Murayama, M., Narikawa, Y., Toyoda, H., Tsurui, T., Maruyama, Y., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117749 · Cited by 9
Commensal microbiota-derived signals regulate host immune system through epigenetic modifications
Takahashi, D., & Hase, K. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.129 · Cited by 3
Metadata
- Authors
- Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S.
- Affiliations
- Harvard University (US)
- AstraZeneca, RAD-Transgenic, Mölndal, Sweden.
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2013-08-02
- Volume
- 341
- Issue
- 6145
- Pages
- 569-573
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3807819
- OpenAlex
- W2060185417
- Cited by
- 5,413
- References
- 28
- Citations by year
- 2026: 483 · 2025: 507 · 2024: 556 · 2023: 551 · 2022: 497 · 2021: 560 · 2020: 452 · 2019: 403 · 2018: 344 · 2017: 319 · 2016: 276 · 2015: 226 · 2014: 204 · 2013: 31
- FWCI
- 109.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (R01CA154426)
- National Institute of General Medical Sciences (R01GM099537)
- National Institute of Allergy and Infectious Diseases (K08AI078942)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK098826, F32DK095506, P30DK034854)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- regulatory T cells, Foxp3, short-chain fatty acids, gut microbiota, microbial metabolites, colitis, FFAR2, intestinal inflammation, bacterial fermentation products
- MeSH terms
- Animals, Bacteria, Colitis, Colon, DNA-Binding Proteins, Fatty Acids, Volatile, Fermentation, Germ-Free Life, Homeostasis, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, G-Protein-Coupled, T-Lymphocytes, Regulatory, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.